Current Liabilities
Finance Lease Liability, Current
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2020
Last reportedQ1 2026Apr 29, 2026
How to read this metric
An increase reflects higher short-term lease obligations, impacting near-term cash flow availability.
Detailed definition
This represents the current portion of obligations arising from finance leases that are due within one year. It captures...
Peer comparison
Standardized under modern lease accounting standards (ASC 842/IFRS 16).
Metric ID:
finance_lease_liabilities_currentHistorical Data
9 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $718.40M | $719.00M | $719.70M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $720.00M |
| QoQ Change | — | +0.1% | +0.1% | -100.0% | — | — | — | — | — |
| YoY Change | — | — | — | — | -100.0% | -100.0% | -100.0% | — | — |
Range$0.00 – $720.00M
CAGR+0.1%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Finance Lease Liability, Current at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's finance lease liability, current?
- Regeneron Pharmaceuticals (REGN) reported finance lease liability, current of $720.00M in Q1 2026.
- What does finance lease liability, current mean?
- Lease payments due within the next year.